GSK’s Nucala highlights IL-5 inhibition in reducing COPD exacerbations in eosinophilic patients:… EP News Bureau May 19, 2025 In both groups, Nucala significantly lowered the rate of exacerbations requiring emergency department (ED) visits or…
